AVTR
Avantor·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 3
Consensus Rating "Buy"
Significant Net Income Decline
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About AVTR
Avantor, Inc.
A leading global provider of tools, equipment and chemicals to perform clinical studies
Life Science Tools and Services
--
05/17/2019
New York Stock Exchange
13,500
12-31
Common stock
Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road, Radnor, Pennsylvania 19087
--
Avantor, Inc., was incorporated in Delaware in May 2017. The company is a leading global provider of mission-critical products and services to customers in the biopharmaceutical, healthcare, education and government, and advanced technology and applied materials industries. The company's comprehensive products provide scientists with everything they need to conduct research: materials and consumables, equipment and instruments, as well as services and professional procurement.
Earnings Call
Q1/2025
Estimate EPS0.23
Actual EPS0.23
Estimate Revenue1.61B
Actual Revenue1.58B
Avantor's Q1 2025: Unpacking Contradictions in Bioprocessing Guidance, Tariffs, and Market Dynamics
May 02,2025 07:28
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.25
Actual EPS0.24
Estimate Revenue1.67B
Actual Revenue1.68B
Avantor's Q2 2025: Dissecting Contradictions in Bioprocessing Growth, Customer Challenges, and Competitive Pressures
Aug 01,2025 10:52
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
AVTR has released its 2025 Q3 earnings. EPS was reported at 0.22, versus the expected 0.23, missing expectations. The chart below visualizes how AVTR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
AVTR has released its 2025 Q3 earnings report, with revenue of 1.62B, reflecting a YoY change of -5.28%, and net profit of -711.80M, showing a YoY change of -1331.49%. The Sankey diagram below clearly presents AVTR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
